These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 4809112)

  • 1. Response of man to infection with Vibrio cholerae. I. Clinical, serologic, and bacteriologic responses to a known inoculum.
    Cash RA; Music SI; Libonati JP; Snyder MJ; Wenzel RP; Hornick RB
    J Infect Dis; 1974 Jan; 129(1):45-52. PubMed ID: 4809112
    [No Abstract]   [Full Text] [Related]  

  • 2. Response of man to infection with Vibrio cholerae. II. Protection from illness afforded by previous disease and vaccine.
    Cash RA; Music SI; Libonati JP; Craig JP; Pierce NF; Hornick RB
    J Infect Dis; 1974 Oct; 130(4):325-33. PubMed ID: 4443613
    [No Abstract]   [Full Text] [Related]  

  • 3. The Broad Street pump revisited: response of volunteers to ingested cholera vibrios.
    Hornick RB; Music SI; Wenzel R; Cash R; Libonati JP; Snyder MJ; Woodward TE
    Bull N Y Acad Med; 1971 Oct; 47(10):1181-91. PubMed ID: 5286453
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of a live oral cholera vaccine in human volunteers.
    Woodward WE; Gilman RH; Hornick RB; Libonati JP; Cash RA
    Dev Biol Stand; 1976; 33():108-12. PubMed ID: 782960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers.
    García L; Jidy MD; García H; Rodríguez BL; Fernández R; Año G; Cedré B; Valmaseda T; Suzarte E; Ramírez M; Pino Y; Campos J; Menéndez J; Valera R; González D; González I; Pérez O; Serrano T; Lastre M; Miralles F; Del Campo J; Maestre JL; Pérez JL; Talavera A; Pérez A; Marrero K; Ledón T; Fando R
    Infect Immun; 2005 May; 73(5):3018-24. PubMed ID: 15845509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroepidemiological studies of El Tor cholera in Bangladesh: association of serum antibody levels with protection.
    Glass RI; Svennerholm AM; Khan MR; Huda S; Huq MI; Holmgren J
    J Infect Dis; 1985 Feb; 151(2):236-42. PubMed ID: 3968450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological studies in cholera infection in Calcutta (1966-67).
    Deb BC; Ganguly R; Sinho R; Ghosh AK; Succar BK; Abou-Gareeb AH; Ozawa A; Shrivastava DL; Burrows W
    Indian J Med Res; 1973 Feb; 61(2):169-78. PubMed ID: 4758991
    [No Abstract]   [Full Text] [Related]  

  • 8. [Method of preparation of erythrocytic diagnostic agents for detection of antitoxic and antibacterial antibodies in El Tor cholera].
    Tsybin BP; Taran IF
    Lab Delo; 1975; (3):170-2. PubMed ID: 48596
    [No Abstract]   [Full Text] [Related]  

  • 9. [Serologic response in man to cholera vaccine].
    Di Tommaso I
    Ann Sclavo; 1973; 15(4):445-52. PubMed ID: 4788453
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification and strain differentiation of Vibrio cholerae by using polyclonal antibodies against outer membrane proteins.
    Martínez-Govea A; Ambrosio J; Gutiérrez-Cogco L; Flisser A
    Clin Diagn Lab Immunol; 2001 Jul; 8(4):768-71. PubMed ID: 11427424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
    Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
    Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diarrhoea caused by non-agglutinable Vibrio cholerae (non-cholera Vibrio).
    Zafari Y; Rahmanzadeh S; Zarifi AZ; Fakhar N
    Lancet; 1973 Aug; 2(7826):429-30. PubMed ID: 4124903
    [No Abstract]   [Full Text] [Related]  

  • 13. [Serologic investigations in a village of Haute Volta at the end of a cholera epidemic].
    Saliou P; Dodin A; Lafaye A
    Bull Soc Pathol Exot Filiales; 1977; 70(1):16-22. PubMed ID: 579326
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunity of cholera in man: relative role of antibacterial versus antitoxic immunity.
    Levine MM; Nalin DR; Craig JP; Hoover D; Bergquist EJ; Waterman D; Holley HP; Hornick RB; Pierce NP; Libonati JP
    Trans R Soc Trop Med Hyg; 1979; 73(1):3-9. PubMed ID: 442179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of disease and immunity in cholera: a review.
    Holmgren J; Svennerholm AM
    J Infect Dis; 1977 Aug; 136 Suppl():S105-12. PubMed ID: 197173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial Commentary: Resurrecting a Live Oral Cholera Vaccine.
    Harris JB
    Clin Infect Dis; 2016 Jun; 62(11):1336-7. PubMed ID: 27001802
    [No Abstract]   [Full Text] [Related]  

  • 17. Rapid detection of Vibrio cholerae 0139 in faecal specimens by coagglutination.
    Agarwal V; Biswas M; Pathak AA; Saoji AM
    Indian J Med Res; 1995 Feb; 101():55-6. PubMed ID: 7729848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-year study of the protective efficacy of the oral whole cell plus recombinant B subunit cholera vaccine in Peru.
    Taylor DN; Cárdenas V; Sanchez JL; Bégué RE; Gilman R; Bautista C; Perez J; Puga R; Gaillour A; Meza R; Echeverria P; Sadoff J
    J Infect Dis; 2000 May; 181(5):1667-73. PubMed ID: 10823767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental studies on cholera immunization. 4. The antibody response to formalinized Vibrio cholerae and purified endotoxin with special reference to protective capacity.
    Svennerholm AM
    Int Arch Allergy Appl Immunol; 1975; 49(4):434-52. PubMed ID: 808500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synthesis of current knowledge of cholera].
    Gareri E
    Ann Sclavo; 1973; 15(4):453-94. PubMed ID: 4596224
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.